First human tests begin for new drug NAV-240
Knowledge-focused
Completed
This was an early-stage study to check the basic safety of a new drug called NAV-240 when given multiple times. It involved 24 healthy adults who received either the drug or a placebo (a dummy treatment). The main goal was to see what side effects might occur and to learn how the…
Phase: PHASE1 • Sponsor: Navigator Medicines, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC